GALECTIN THERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Galectin Therapeutics Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Galectin Therapeutics Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 62.3M shares, a 4.53% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 62.3M +2.7M +4.53% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 62.1M +2.57M +4.31% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 61.9M +2.43M +4.08% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 61.8M +2.42M +4.08% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 59.6M +186K +0.31% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 59.6M +194K +0.33% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 59.4M +84.7K +0.14% Dec 31, 2022 10-K 2024-03-29
Q3 2022 59.4M +84.7K +0.14% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 59.4M +121K +0.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 59.4M +2.2M +3.85% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 59.3M +2.26M +3.97% Dec 31, 2021 10-K 2023-03-30
Q3 2021 59.3M +2.26M +3.97% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 59.3M +2.38M +4.18% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 57.2M +292K +0.51% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 57.1M +182K +0.32% Dec 31, 2020 10-K 2022-03-31
Q3 2020 57.1M +418K +0.74% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 56.9M +303K +0.54% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 56.9M +11.3M +24.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 56.9M +15.7M +38.1% Dec 31, 2019 10-K 2021-03-31
Q3 2019 56.7M +15.5M +37.7% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 56.6M +16M +39.3% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 45.6M +7.95M +21.1% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 41.2M +5.4M +15.1% Dec 31, 2018 10-K 2020-03-16
Q3 2018 41.1M +5.5M +15.4% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 40.6M +5.66M +16.2% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 37.6M +2.98M +8.58% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 35.8M +2.88M +8.74% Dec 31, 2017 10-K 2019-03-06
Q3 2017 35.6M +6.24M +21.2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 35M +5.69M +19.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 34.7M +5.69M +19.6% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 32.9M +4.09M +14.2% Dec 31, 2016 10-K 2018-03-29
Q3 2016 29.4M +5.47M +22.8% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 29.3M +5.49M +23.1% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 29M +5.25M +22.1% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28.8M +6.55M +29.4% Dec 31, 2015 10-K 2017-03-28
Q3 2015 23.9M +1.81M +8.16% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 23.8M +1.75M +7.96% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 23.7M +1.82M +8.33% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 22.3M +3.89M +21.2% Dec 31, 2014 10-K 2016-03-15
Q3 2014 22.1M +4.47M +25.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 22M +5.74M +35.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 21.9M +5.72M +35.3% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 18.4M +2.33M +14.5% Dec 31, 2013 10-K 2015-03-18
Q3 2013 17.7M +1.68M +10.6% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 16.3M +480K +3.04% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 16.2M +520K +3.32% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 16.1M +3.14M +24.3% Dec 31, 2012 10-K 2014-03-21
Q3 2012 16M -60.9M -79.2% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 15.8M -58.2M -78.6% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 15.7M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 12.9M +2.27M +21.3% Dec 31, 2011 10-K 2013-03-29
Q3 2011 76.9M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 74.1M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 10.7M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.